Literature DB >> 29046461

Human Embryonic Stem Cell-Derived Neurons Are Highly Permissive for Varicella-Zoster Virus Lytic Infection.

Tomohiko Sadaoka1,2, Cindi L Schwartz3, Labchan Rajbhandari4, Arun Venkatesan4, Jeffrey I Cohen5.   

Abstract

Varicella-zoster virus (VZV) is highly cell associated when grown in culture and has a much higher (4,000- to 20,000-fold increased) particle-to-PFU ratio in vitro than herpes simplex virus (HSV). In contrast, VZV is highly infectious in vivo by airborne transmission. Neurons are major targets for VZV in vivo; in neurons, the virus can establish latency and reactivate to produce infectious virus. Using neurons derived from human embryonic stem cells (hESC) and cell-free wild-type (WT) VZV, we demonstrated that neurons are nearly 100 times more permissive for WT VZV infection than very-early-passage human embryonic lung cells or MRC-5 diploid human fibroblasts, the cells used for vaccine production or virus isolation. The peak titers achieved after infection were ∼10-fold higher in human neurons than in MRC-5 cells, and the viral genome copy number-to-PFU ratio for VZV in human neurons was 500, compared with 50,000 for MRC-5 cells. Thus, VZV may not necessarily have a higher particle-to-PFU ratio than other herpesviruses; instead, the cells previously used to propagate virus in vitro may have been suboptimal. Furthermore, based on electron microscopy, neurons infected with VZV produced fewer defective or incomplete viral particles than MRC-5 cells. Our data suggest that neurons derived from hESC may have advantages compared to other cells for studies of VZV pathogenesis, for obtaining stocks of virus with high titers, and for isolating VZV from clinical specimens.IMPORTANCE Varicella-zoster virus (VZV) causes chickenpox and shingles. Cell-free VZV has been difficult to obtain, both for in vitro studies and for vaccine production. While numerous cells lines have been tested for their ability to produce high titers of VZV, the number of total virus particles relative to the number of viral particles that can form plaques in culture has been reported to be extremely high relative to that in other viruses. We show that VZV grows to much higher titers in human neurons than in other cell types in vitro and that the number of total virus genomes relative to the number of viral particles that can form plaques in culture is much lower in human neurons than other cultured cells. These findings indicate that human neurons may be useful for studying VZV in vitro, for growing preparations of virus with high titers, and for isolating the virus from human samples.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  particle/PFU ratio; varicella-zoster virus

Mesh:

Year:  2017        PMID: 29046461      PMCID: PMC5730782          DOI: 10.1128/JVI.01108-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Chickenpox and herpes zoster. III. Tissue culture studies.

Authors:  D TAYLOR-ROBINSON
Journal:  Br J Exp Pathol       Date:  1959-12

2.  Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation.

Authors:  Sravya Kurapati; Tomohiko Sadaoka; Labchan Rajbhandari; Balaji Jagdish; Priya Shukla; Mir A Ali; Yong Jun Kim; Gabsang Lee; Jeffrey I Cohen; Arun Venkatesan
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Automated electron microscope tomography using robust prediction of specimen movements.

Authors:  David N Mastronarde
Journal:  J Struct Biol       Date:  2005-10       Impact factor: 2.867

4.  A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1.

Authors:  W Cai; P A Schaffer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Eclipse phase of herpes simplex virus type 1 infection: Efficient dynein-mediated capsid transport without the small capsid protein VP26.

Authors:  Katinka Döhner; Kerstin Radtke; Simone Schmidt; Beate Sodeik
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Diagnosis of acute and latent varicella-zoster virus infections using the polymerase chain reaction.

Authors:  D Dlugosch; A M Eis-Hübinger; J P Kleim; R Kaiser; E Bierhoff; K E Schneweis
Journal:  J Med Virol       Date:  1991-10       Impact factor: 2.327

7.  Cell-free varicella-zoster virus in cultured human melanoma cells.

Authors:  C Grose; D M Perrotta; P A Brunell; G C Smith
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

Review 8.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

9.  An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons.

Authors:  Amos Markus; Ilana Lebenthal-Loinger; In Hong Yang; Paul R Kinchington; Ronald S Goldstein
Journal:  PLoS Pathog       Date:  2015-06-04       Impact factor: 6.823

10.  Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection.

Authors:  Katherine S Lee; Wenbo Zhou; Jonah J Scott-McKean; Kaitlin L Emmerling; Guang-yun Cai; David L Krah; Alberto C Costa; Curt R Freed; Myron J Levin
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  10 in total

1.  Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons.

Authors:  Labchan Rajbhandari; Priya Shukla; Balaji Jagdish; Abby Mandalla; Qingxue Li; Mir A Ali; Hojae Lee; Gabsang Lee; Tomohiko Sadaoka; Jeffrey I Cohen; Arun Venkatesan
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

Review 2.  Impact of Cultured Neuron Models on α-Herpesvirus Latency Research.

Authors:  Angus C Wilson
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

Review 3.  Molecular Aspects of Varicella-Zoster Virus Latency.

Authors:  Daniel P Depledge; Tomohiko Sadaoka; Werner J D Ouwendijk
Journal:  Viruses       Date:  2018-06-28       Impact factor: 5.048

Review 4.  Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Authors:  Lillian Laemmle; Ronald S Goldstein; Paul R Kinchington
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

5.  Mutagenesis of the Varicella-Zoster Virus Genome Demonstrates That VLT and VLT-ORF63 Proteins Are Dispensable for Lytic Infection.

Authors:  Shirley E Braspenning; Robert Jan Lebbink; Daniel P Depledge; Claudia M E Schapendonk; Laura A Anderson; Georges M G M Verjans; Tomohiko Sadaoka; Werner J D Ouwendijk
Journal:  Viruses       Date:  2021-11-16       Impact factor: 5.818

6.  A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation.

Authors:  Tomohiko Sadaoka; Daniel P Depledge; Labchan Rajbhandari; Judith Breuer; Arun Venkatesan; Jeffrey I Cohen
Journal:  mBio       Date:  2022-08-02       Impact factor: 7.786

7.  Modelling Lyssavirus Infections in Human Stem Cell-Derived Neural Cultures.

Authors:  Vinod Sundaramoorthy; Nathan Godde; Ryan J Farr; Diane Green; John M Haynes; John Bingham; Carmel M O'Brien; Megan Dearnley
Journal:  Viruses       Date:  2020-03-25       Impact factor: 5.048

Review 8.  Varicella-Zoster Virus Infection of Neurons Derived from Neural Stem Cells.

Authors:  Peter G E Kennedy; Trine H Mogensen
Journal:  Viruses       Date:  2021-03-15       Impact factor: 5.048

Review 9.  Recent Issues in Varicella-Zoster Virus Latency.

Authors:  Peter G E Kennedy; Trine H Mogensen; Randall J Cohrs
Journal:  Viruses       Date:  2021-10-07       Impact factor: 5.048

10.  Decoding the Architecture of the Varicella-Zoster Virus Transcriptome.

Authors:  Werner J D Ouwendijk; Daniel P Depledge; Shirley E Braspenning; Tomohiko Sadaoka; Judith Breuer; Georges M G M Verjans
Journal:  mBio       Date:  2020-10-06       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.